Briacell Therapeutics Corp

NASDAQ BCTX

Data sourced from iex and EODHD
Download Data

Briacell Therapeutics Corp Income Statement 2006 - 2023

This table shows the Income Statement for Briacell Therapeutics Corp going from 2006 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31 2018-07-31 2017-07-31 2016-07-31 2015-07-31 2014-07-31 2013-07-31 2012-07-31 2011-07-31 2010-07-31 2009-07-31 2008-07-31 2007-07-31 2006-07-31
Revenue
M 0 0 0 0 0 0 - - - - - - - - - - - -
Cost of Revenue
M 0 0 0 0 - - - - - - - - - - - - - -
Gross Profit
M 0 0 0 0 - - - - - - - - - - - - - -
Operating Expenses
M 23 15 -4 -1 - - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 8 7 4 1 1 1 1 1 1 0 0 1 1 0 0 - - -
Research and Development (R&D) Expenses
M 15 8 1 2 4 2 2 1 0 - - - - - - - - -
Other Operating Expenses
M 0 0 -9 -5 - - - - - - - - - - - - - -
Costs and Expenses
M 23 0 -4 -1 - - - - - - - - - - - - - -
Operating Income
M -23 -15 4 1 1 -4 -3 -2 -1 0 0 -1 -1 0 0 0 0 0
Interest Expense
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 2 4 7 0 0 0 0 0 -1 -8 0 0 0 -1 0 - - -
EBT
M -20 -12 4 1 1 1 -3 -2 -3 -8 0 -1 -1 -1 0 - - -
Income Tax Provision
M - 0 7 0 0 2 1 1 2 8 0 0 0 1 0 0 0 0
Income after Tax
M - -12 -3 1 1 -1 -3 -2 -5 -17 0 -1 -1 -2 0 - - -
Non-Controlling Interest
M - 12 0 0 0 0 0 - - - - - - - - - - -
Net Income
M - -27 0 -5 -6 -5 -3 - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 15,619,676.00 15,494,091.00 4,519,579.00 713,889.00 579,664.00 427,815.00 352,979.00 288,443.00 249,178.00 59,002.00 59,002.00 58,830.00 32,670.00 18,169.00 8,930.00 4,837.00 4,169.00 2,051.00
EBITDA
M -22 -12 4 1 1 1 -3 -2 0 7 0 0 -1 0 0 0 0 0
Depreciation and Amortization
M 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -22 -15 4 1 1 1 -3 -2 0 7 0 0 -1 0 0 0 0 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% - -0.27 178.45 -5.22 36.32 149.59 -24.71 -32.32 -76.38 -103.72 12.03 20.18 2.20 -65.38 -5.38 - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 0 0 0 - - - - - - - - - - -
Gross Profit Margin
% - - - - - - - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email